Tobacco smoke exposure limits the therapeutic benefit of tezacaftor/ivacaftor in pediatric patients with cystic fibrosis is a research paper published in Journal of Cystic Fibrosis (2020). On theSindex it has a DataRank of 0. It has been cited 34 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: HARRIS19A0-KB
National Institutes of Health
Grant: K08HL140190
National Institutes of Health
Grant: P30DK72482
NHLBI NIH HHS
Grant: R35 HL135816
NIDDK NIH HHS
Grant: P30 DK072482
National Institutes of Health
Grant: 3P30DK072482-03S3
UAB CF Research and Translation Core Center
National Institutes of Health
Grant: 5K08HL140190-02
Overcoming barriers to F508del CFTR correction
FWCI
2.74
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals